Immune therapy in haematological malignancies

Martin S. Tallman

doi:10.1016/j.beha.2006.07.001

Immune therapy in haematological malignancies

Martin S. Tallman^*

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	635-636
Number of pages	2
Journal	Best Practice and Research: Clinical Haematology
Volume	19
Issue number	4
DOIs	https://doi.org/10.1016/j.beha.2006.07.001
State	Published - Dec 2006
Externally published	Yes

ASJC Scopus subject areas

Oncology
Clinical Biochemistry

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.beha.2006.07.001

Cite this

@article{30bbddf2a2fa4313a48c6a787ccbb7f1,

title = "Immune therapy in haematological malignancies",

author = "Tallman, {Martin S.}",

year = "2006",

month = dec,

doi = "10.1016/j.beha.2006.07.001",

language = "English (US)",

volume = "19",

pages = "635--636",

journal = "Best Practice and Research: Clinical Haematology",

issn = "1521-6926",

publisher = "Bailliere Tindall Ltd",

number = "4",

}

TY - JOUR

T1 - Immune therapy in haematological malignancies

AU - Tallman, Martin S.

PY - 2006/12

Y1 - 2006/12

UR - http://www.scopus.com/inward/record.url?scp=33748704459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748704459&partnerID=8YFLogxK

U2 - 10.1016/j.beha.2006.07.001

DO - 10.1016/j.beha.2006.07.001

M3 - Editorial

C2 - 16997173

AN - SCOPUS:33748704459

SN - 1521-6926

VL - 19

SP - 635

EP - 636

JO - Best Practice and Research: Clinical Haematology

JF - Best Practice and Research: Clinical Haematology

IS - 4

ER -

Immune therapy in haematological malignancies

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this